We are monitoring the impact of COVID-19 on Latin America Preventive Vaccine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 119
Share on
Share on

Latin America Preventive Vaccine Market Research Report - By Vaccine Type, By End User, By Country (Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021-2026)

Pulished: April, 2021
ID: 119
Pages: 145

Latin America Preventive Vaccine Market Size (2021 to 2026)

The size of the Preventive Vaccine Market in Latin America is expected to reach USD 9.68 billion by 2026 from USD 5.22 billion in 2021, growing at a CAGR of 13.17% during the forecast period.

The market for preventive vaccine market is growing at a significant pace in Latin America. In some disease categories, portfolios, and other illnesses, preventative vaccination vaccines have fully matured, and the market is growing as a result. Infectious diseases are the leading causes of death in Latin America, and they pose some of the region's most serious health and security challenges. In addition, infectious illnesses are among the main causes of death in the region. Therefore, the proliferation of contagious diseases is driving the market growth in the region. Scientists are currently performing research and development to develop a preventive vaccine for the treatment of these diseases.

Also, the prevalence of chronic diseases such as cancer and growing awareness about disease prevention boosts the market during the forecast period. In addition, improving innovative technology in vaccine development in the region is the major factor driving the market. 

The other factors, such as increasing healthcare expenditure, growing demand for preventive vaccines, and evolving vaccine technologies, are majorly propelling the market growth. In addition, increasing investment and funding by the government and private organizations to develop various vaccine development of laboratories are expected to increase the market growth. Furthermore, emerging economies such as Mexico and Brazil are boosting market growth by focusing more on creating novel vaccines such as DNA vaccines and raising awareness about the advantages of vaccination.

However, the emergence of the global pandemic has caused unprecedented loss to the market sector. Scientists from various countries are performing research and development activities for vaccine development to treat the Novel coronavirus. Hence the demand for the preventive vaccine is rapidly increased. The market is anticipated to have a significant share in the coming years. 

Healthcare expenses, on the other hand, are skyrocketing, and prevention is becoming incredibly common. For example, vaccination costs have risen from single digits to triple digits many times in the last two decades, posing serious challenges for doctors and their patients and putting a burden on public health resources.

This research report segmented and sub-segmented the Latin American Preventive Vaccines Market into the following categories:

By Vaccine Type:

  • Live, Attenuated Vaccines
  • Inactivated Vaccines             
  • Toxoid Vaccines    
  • Subunit Vaccines  
  • Conjugate Vaccines             
  • DNA Vaccines         
  • Recombinant Vector Vaccines          

By End-User:

  • Pediatric Vaccine
    • Pneumococcal
    • MMR
    • Varicella
    • Hepatitis
    • Poliovirus
    • HIB
    • Others
  • Adult Vaccines      
    • Influenza
    • Cervical Cancer
    • Hepatitis
    • Zoster
    • Others

By Country:

  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Latin American preventive vaccines market is projected to witness a promising market share during the forecast period. The regional market's growth is attributed to the proliferation of chronic diseases, varying degrees of increase in the demand for vaccination for separate diseases over time, and growing awareness of preventive care. Also, the improving healthcare sector owing to the rising funding by the government and development of vaccine laboratories are augmenting the market growth over the forecast period. Other important aspects include developing manufacturing facilities or plants, using new technology, recent mergers and acquisitions, major player partnerships, and collaboration are expanding the market growth in Latin America. Brazil and Mexico are the two major countries in Latin America, significantly contributing to the regional market growth. The market growth in these countries is fuelled by increasing disposable income, rising healthcare expenditure, and government initiatives for vaccine development.

KEY MARKET PLAYERS:

The most prominent companies leading the Latin America Preventive Vaccine Market profiled in the report are GlaxoSmithKline, PLC, Bavarian Nordic, Merck and Company, CSL Limited, Novartis AG, Emergent BioSolutions Inc., Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                           

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                              

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                            

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                     

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                               

  1. Market Segmentation

                5.1 By Vaccine Type                                                                       

                                5.1.1 Live, Attenuated Vaccines                                                

                                5.1.2 Inactivted Vaccines                                                             

                                5.1.3 Toxoid Vaccines                                                    

                                5.1.4 Subunit vaccines                                                  

                                5.1.5 Conjugate vaccines                                                             

                                5.1.6 DNA vaccines                                                         

                                5.1.7 Recombinant vector vaccines                                                          

                5.2 By End User                                                               

                                5.2.1 Paediatric Vaccine                                               

                                                5.2.1.1 Pneumococcal                                   

                                                5.2.1.2 MMR                                     

                                                5.2.1.3 Varicella                               

                                                5.2.1.4 Hepatitis                                              

                                                5.2.1.5 Poliovirus                                             

                                                5.2.1.6 HIB                                         

                                                5.2.1.7 Others                                  

                                5.2.2 Adult Vaccines                                                      

                                                5.2.2.1 Influenza                                             

                                                5.2.2.2 Cervical Cancer                                 

                                                5.2.2.3 Hepatitis                                              

                                                5.2.2.4 Zoster                                   

                                                5.2.2.5 Others                                  

  1. Geographical Analysis

                6.1 Introduction                                                                              

                6.2 Brazil                                                                             

                6.3 Argentina                                                                    

                6.4 Mexico                                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                      

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                               

                                7.2.5 Competitive Rivalry within the Industry                                                      

  1. Market Leaders' Analysis

                8.1 GlaxoSmithKline, plc.                                                                             

                                8.1.1 Overview                                                

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                            

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Merck and Company                                                                              

                8.3 Bavarian Nordic                                                                        

                8.4 CSL Limited                                                                 

                8.5 Emergent BioSolutions Inc.                                                                  

                8.6 Novartis AG                                                                

                8.7 Johnson and Johnson                                                                             

                8.8 MedImmune, LLC                                                                    

                8.9 Pfizer, Inc.                                                                   

                8.10 Sanofi Pasteur                                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                                          

                9.4 New Product Launches                                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Preventive Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  2. Latin America Preventive Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Billion)
  3. Latin America Live, Attenuated Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Inactivated Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  5. Latin America Toxoid Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Subunit vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Conjugate vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  8. Latin America DNA vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Recombinant vector vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Preventive Vaccines Market, By End User, From 2021 to 2026 (USD Billion)
  11. Latin America Paediatric Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  12. Latin America Adult Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Paediatric Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  14. Latin America Pneumococcal Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  15. Latin America MMR Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  16. Latin America Varicella Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  17. Latin America Hepatitis Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  18. Latin America Poliovirus Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  19. Latin America HIB Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  20. Latin America Other Paediatric Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  21. Latin America Adult Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  22. Latin America Influenza Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  23. Latin America Cervical Cancer Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  24. Latin America Hepatitis Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  25. Latin America Zoster Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  26. Latin America Other Adult Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  27. Brazil Preventive Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Billion)
  28. Brazil Preventive Vaccines Market, By End User, From 2021 to 2026 (USD Billion)
  29. Argentina Preventive Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Billion)
  30. Argentina Preventive Vaccines Market, By End User, From 2021 to 2026 (USD Billion)
  31. Mexico Preventive Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Billion)
  32. Mexico Preventive Vaccines Market, By End User, From 2021 to 2026 (USD Billion)
  33. Brazil Paediatric Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  34. Argentina Paediatric Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  35. Mexico Paediatric Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  36. Brazil Adult Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  37. Argentina Adult Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  38. Mexico Adult Vaccines Market, By Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample